Bausch Health Companies (BHC) Dividends payables (2009 - 2010)
Bausch Health Companies (BHC) posted Dividends payables of $15.1 million for Q3 2010, up 5.77% sequentially from $14.3 million in Q2 2010, and up 5.88% YoY from $14.2 million in Q3 2009.
Bausch Health Companies (BHC) Dividends payables (2009 - 2010) Analysis & Trends
Bausch Health Companies has reported Dividends payables for 2 years, with the latest figure at $15.1 million in Q3 2010.
- Quarterly Dividends payables rose 5.88% year-over-year to $15.1 million in Q3 2010, while the trailing twelve-month figure through Sep 2010 was $15.1 million (up 5.88% YoY) and the FY2009 annual result came in at $14.2 million, changed N/A from the prior year.
- Dividends payables rose to $15.1 million in Q3 2010 per BHC's latest filing, from $14.3 million in the prior quarter.
- Over five years, Dividends payables peaked at $59.3 million in Q2 2009 and troughed at $14.2 million in Q3 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.82 Bn | 40.16 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.64 Bn | 30.96 Bn | 1.05 Bn | 221.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.38 Bn | 19.71 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.88 Bn | 17.99 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 730.75 Mn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | 15.08 Mn |
| Jun 30, 2010 | 14.26 Mn |
| Dec 31, 2009 | 14.25 Mn |
| Sep 30, 2009 | 14.24 Mn |
| Jun 30, 2009 | 59.33 Mn |